Tag: Profit/loss
-
Dannex Ayrton Starwin Plc records over GHS 95 million revenue in 2022
Pharmaceutical company, Dannex Ayrton Starwin PLC remains resolute in restoring profitability after it achieved a revenue of a little over GHS 95 million in 2022 surpassing the over GHS 74 million recorded in 2021. The company however recorded exchange losses of about GHS 9.1 million under the year of review. Delivering his address at the…